How We Lead – Perspectives from Two Key Biotechnology Hubs in North America

March 8, 2021 11:30 AM - 1:15 PM

Webinar, click "live-stream" button to view

Add to Calendar 3/8/2021 11:30:00 AM 3/8/2021 1:15:00 PM How We Lead – Perspectives from Two Key Biotechnology Hubs in North America

Join us on International Women’s Day, March 8, 2021, when WIB-Greater Montreal and WIB-Greater Boston will present a joint event with BIOQuébec and MassBio.

BIOQuébec is committed to supporting Québec’s biotechnology and life sciences industry. MassBio’s mission is to advance Massachusetts’ leadership in the life sciences and each is dedicated to improving healthcare and quality of life. Join the discussion of the landscape in Quebec and Massachusetts and biotech leaders’ perspectives on challenges/obstacles faced, leadership styles, where do we want to be, and how do we get there.

The event will be facilitated by journalist-columnist Tasha Kheiriddin with panelists from Québec: Anie Perrault, executive director BIOQuébec, Clarissa Desjardins, founder and former CEO, Clementia (now Ipsen), and Nadine Beauger, President & CEO, IRICOR and from Massachusetts: Kendalle Burin O’Connell, President & COO MassBio, Ramani Varanasi- President & CEO of X-Biotix Therapeutics, and Liang Schweizer- CEO & CSO of HiFiBiO Therapeutics.

PLEASE NOTE: You will be redirected to the Women In Bio event page by clicking, "Register Now." This event requires you to sign-in to receive a personalized link to the webinar. Please select “sign-in” and then choose “non-member.” The event is free for all MassBio members.

Disclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable, please be sure to turn off your webcam.

 Webinar, click "live-stream" button to view
Co-founder, President & CEO, HiFiBiO Therapeutics
Liang Schweizer is the co-founder, President and CEO of HiFiBiO Therapeutics, an emerging multinational biotherapeutics company. Previously, she was a co-founder and CSO for Harbour Biomed. Before launching her entrepreneurial career, Liang served as Head of Asian Cancer Research at Sanofi and Director of Leads Evaluation at Bristol-Myers Squibb Company. Under her leadership, her various teams made significant contributions to 4 marketed drugs and impacted over 20 clinical candidates. She is also a co-inventor of multiple immunomodulation drug candidates. Liang Schweizer graduated from the University of Science and Technology of China (USTC) majoring in Biology. She received her Master’s degree in Microbial Engineering at the University of Minnesota with minor in Chemical Engineering. Liang earned her Ph.D in Molecular Biology from the University in Zurich, Switzerland. Her postdoctoral training was with Dr. Harold Varmus, a Nobel Laureate, at Memorial Sloan Kettering Cancer Center (MSKCC), New York.